China approves home-grown vaccines, offering alternative to global drugmakers' products

China has approved a pneumonia vaccine developed by Chinese drugmaker Walvax Biotechnology's unit, its National Medical Products Administration said in a notice on Tuesday, offering an alternative to one of Pfizer's best-selling products Prevnar 13.

Chinese officials investigate cause of pneumonia outbreak in Wuhan

Chinese health authorities said they are investigating 27 cases of viral pneumonia in the central city of Wuhan, after rumors on social media suggested the outbreak could be linked to Severe Acute Respiratory Syndrome (SARS).

California pharmacies rarely take back unused opioids

(Reuters Health) - Only 1 in 10 California pharmacies have programs to take back unused prescription opioids and just one in five give consumers accurate disposal information, according to a study that suggests drugstores could do more to help combat substance abuse.

Syrian med students trade translation services for e-learning access

(Reuters Health) - Arabic-speaking medical students in war-torn Syria are providing translation services to an online educational company in exchange for free access to videos that teach clinical processes and procedures.

Low levels of environmental pollutants may slow fetal growth

(Reuters Health) - Pollutants that persist for decades in the environment may affect fetal growth, a U.S. study suggests.

Diet Dr Pepper does not promise weight loss or deceive consumers: U.S. appeals court

A U.S. federal appeals court on Monday said the maker of Diet Dr Pepper did not deceive consumers into thinking the soft drink promoted weight loss by including "diet" in its name, a decision that could doom a similar lawsuit over Diet Coke.

Eye injuries from laundry pods rising in U.S.

(Reuters Health) - A growing number of kids are getting chemicals from laundry detergent pods in their eyes, even as ocular injuries from other types of household cleaners steadily decline, a U.S. study suggests.

Chinese court sentences 'gene-editing' scientist to three years in prison

A Chinese court sentenced the scientist who created the world's first "gene-edited" babies to three years in prison on Monday for illegally practising medicine and violating research regulations, the official Xinhua news agency said.

Sol-Gel acne cream reduces marks in late-stage studies, shares soar

Sol-Gel Technologies Ltd's shares more than tripled in value on Monday after the company said its lead acne drug candidate, Twyneo, met the main goal of reducing marks in two late-stage studies.

China bans imports of pigs from Indonesia due to African swine fever

China's customs said it has banned imports of pigs, wild boars and related products from Indonesia due to African swine fever.

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca and Merck's ovarian cancer drug Lynparza has received U.S. regulatory approval for the treatment of advanced pancreatic cancer, cementing its lead in a niche category of cancer treatments.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS